ReviewMaterials today. Bio2025
Nanotherapies based on bacterial metabolism: Mechanisms, design and application.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Green synthesis of a manganese oxide-selenium nanocomposite using watermelon peel waste with antimicrobial and mosquitocidal activities.RSC advances · 2026Article
- Bacterial phospholipid selective quaternary phosphonium polymers with potent antibacterial activity.Materials today. Bio · 2026Article
- Targeting multidrug-resistantMaterials today. Bio · 2026Article
- Multifunctional FePharmaceutics · 2026Article
- Applications of nanoparticles in plant disease identification and control for sustainable crop production.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial metabolism provides the essential materials and energy for growth and reproduction. Through complex transformations and electron transfer, bacteria convert external nutrients into useable forms and achieve pathogenicity in the human body. In recent years, with the global spread of antibiotic resistance, traditional antibiotic treatments have become increasingly ineffective and may even exacerbate the imbalance of the human microbiota. As a novel type of antibacterial agent, nanomaterials possess superior characteristics when compared with traditional antibiotics. The most significant feature is their capacity to target multiple stages of bacterial metabolism, which endows them with substantial potential in the realm of antibacterial therapy. In the early stages of nutrient entry into bacterial metabolism, nanomaterials can not only induce oxidative stress imbalance and interrupt the transformation of metabolic substances, but also hinder the energy production process by disrupting the cell membrane or interfering with the operation of the electron transport chain. Moreover, through rational and meticulous design in terms of size, surface properties, solubility, and catalytic effects, nanomaterials can exhibit even more considerable antimicrobial potential. Therefore, this article, starting from the perspective of bacterial metabolism, provides a detailed discussion on the antimicrobial mechanisms, application background, and challenges and opportunities faced by nanomaterials, with the aim of guiding future research and promoting the further development of nanomaterials in the field of antimicrobial therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.